{"id":379192,"date":"2020-11-12T01:03:21","date_gmt":"2020-11-12T06:03:21","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=379192"},"modified":"2020-11-12T01:03:21","modified_gmt":"2020-11-12T06:03:21","slug":"innate-pharma-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"Innate Pharma to Participate in upcoming investor conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MARSEILLE, France, Nov.  12, 2020  (GLOBE NEWSWIRE) &#8212; Innate Pharma SA (Euronext Paris: IPH \u2013 ISIN: FR0010331421; Nasdaq: IPHA) (\u201c<strong>Innate<\/strong>\u201d or the \u201c<strong>Company<\/strong>\u201d), today announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences.<\/p>\n<ul>\n<li>\n          <strong>Bryan Garnier &amp; Co Virtual European Healthcare Conference<\/strong><br \/>\n          <br \/> Date: November 17, 2020 <br \/> Fireside Chat: November 17, 2020 at 10:00 a.m. CET<\/p>\n<\/li>\n<li>\n          <strong>Jefferies Virtual London Healthcare Conference<\/strong><br \/>\n          <br \/> Date: November 18, 2020<\/p>\n<\/li>\n<li>\n          <strong>SVB Leerink Oncology 1&#215;1 Day<\/strong><br \/>\n          <br \/> Date: November 19, 2020<\/p>\n<\/li>\n<li>\n          <strong>Oddo &#8211; Tech40 Digital Forum 5<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Edition<\/strong><br \/>\n          <br \/> Date: November 24-25, 2020<\/p>\n<\/li>\n<li>\n          <strong>Evercore ISI 3<\/strong><br \/>\n          <sup><br \/>\n            <strong>rd<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual HealthCONx<\/strong><br \/>\n          <br \/> Date: December 1-3, 2020 <br \/> Fireside Chat: December 2, 2020 at 8:50-9:10 a.m. ET<\/li>\n<\/ul>\n<p align=\"justify\">A replay of Innate\u2019s presentation at the Bryan Garnier conference and a live webcast of Innate\u2019s presentation at the Evercore ISI conference will be accessible through the News &amp; Events page of the Investors section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8VG4qYYOXX-s2DsviNwqemo5pv4JB6hxrbqzC6gU1P3lyHUia6BymVbLnU3kyTk1yN6cPOTIxBcjpqjRoL2TtBpDM0vNIzsVA9v8pM1_Cq0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.innate-pharma.com<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Innate Pharma:<\/strong><br \/>\n        <br \/> Innate Pharma S.A. is a commercial stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.<\/p>\n<p align=\"justify\">Innate Pharma\u2019s commercial-stage product, Lumoxiti, in-licensed from AstraZeneca in the US, EU and Switzerland, was approved by the FDA in September 2018. Lumoxiti is a first-in class specialty oncology product for hairy cell leukemia. Innate Pharma\u2019s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.<\/p>\n<p align=\"justify\">Innate has been a pioneer in the understanding of natural killer cell biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb, Novo Nordisk A\/S, Sanofi, and a multi-products collaboration with AstraZeneca.<\/p>\n<p align=\"justify\">Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US. <br \/> Learn more about Innate Pharma at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8VG4qYYOXX-s2DsviNwqenwazhLuLeU93RtICy-LrI9q008SNxq_vPq4RDicC5X2DatRy-PvKsMt2eKVkedODDzlhM5E6v6fefz2EC3tTUA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.innate-pharma.com <\/u><\/a><\/p>\n<p align=\"justify\">\n        <strong>Information about Innate Pharma shares:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;text-align: left;vertical-align: middle\">\n            <strong>ISIN code<\/strong><br \/>\n            <br \/>\n            <strong>Ticker code<\/strong><br \/>\n            <br \/>\n            <strong>LEI<\/strong>\n          <\/td>\n<td style=\"max-width:80%;width:80%;min-width:80%;text-align: left;vertical-align: middle\">FR0010331421 <br \/> Euronext: IPH Nasdaq: IPHA <br \/> 9695002Y8420ZB8HJE29<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong>Disclaimer on forward-looking information and risk factors: <\/strong><br \/>\n        <br \/> This press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995.The use of certain words, including \u201cbelieve,\u201d \u201cpotential,\u201d \u201cexpect\u201d and \u201cwill\u201d and similar expressions, is intended to identify forward-looking statements. Although the company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Company\u2019s commercialization efforts, the Company\u2019s continued ability to raise capital to fund its development and the overall impact of the COVID-19 outbreak on the global healthcare system as well as the Company\u2019s business, financial condition and results of operations. For an additional discussion of risks and uncertainties which could cause the company&#8217;s actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors (\u201cFacteurs de Risque&#8221;) section of the Universal Registration Document filed with the French Financial Markets Authority (\u201cAMF\u201d), which is available on the AMF website http:\/\/www.amf-france.org or on Innate Pharma\u2019s website, and public filings and reports filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d), including the Company\u2019s Annual Report on Form 20-F for the year ended December 31, 2019, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public, by the Company.<\/p>\n<p align=\"justify\">This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.<\/p>\n<p align=\"justify\">\n        <strong>For additional information, please contact:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:30%;width:30%;min-width:30%;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong><br \/>\n              <u>Investors<br \/><\/u><br \/>\n            <\/strong><br \/>\n            <br \/>\n            <strong>Innate Pharma<\/strong><br \/>\n            <br \/> Tel.: +33 (0)4 30 30 30 30<br \/><a href=\"mailto:investors@innate-pharma.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>investors@innate-pharma.com<\/u><\/a><\/p>\n<\/td>\n<td style=\"max-width:70%;width:70%;min-width:70%;text-align: justify;vertical-align: middle\">\n            <strong><br \/>\n              <u>Media<br \/><\/u><br \/>\n            <\/strong><br \/>\n            <br \/>\n            <strong>Innate Pharma<\/strong><br \/>\n            <br \/> Tracy Rossin (Global\/US)<br \/> Tel.: +1 240 801 0076<br \/><a href=\"mailto:Tracy.Rossin@innate-pharma.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Tracy.Rossin@innate-pharma.com<\/u><\/a><\/p>\n<p><strong>ATCG Press<\/strong><br \/> Marie Puvieux (France)<br \/> Tel.: +33 (0)9 81 87 46 72<br \/><a href=\"mailto:innate-pharma@atcg-partners.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>innate-pharma@atcg-partners.com<\/u><\/a><\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzkwMCMzODIwNzc3IzEwMTE0NTA=\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MARSEILLE, France, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Innate Pharma SA (Euronext Paris: IPH \u2013 ISIN: FR0010331421; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d), today announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences. Bryan Garnier &amp; Co Virtual European Healthcare Conference Date: November 17, 2020 Fireside Chat: November 17, 2020 at 10:00 a.m. CET Jefferies Virtual London Healthcare Conference Date: November 18, 2020 SVB Leerink Oncology 1&#215;1 Day Date: November 19, 2020 Oddo &#8211; Tech40 Digital Forum 5 th Edition Date: November 24-25, 2020 Evercore ISI 3 rd Annual HealthCONx Date: December 1-3, 2020 Fireside Chat: December 2, 2020 at 8:50-9:10 a.m. ET A replay of Innate\u2019s presentation at the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Innate Pharma to Participate in upcoming investor conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-379192","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Innate Pharma to Participate in upcoming investor conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innate Pharma to Participate in upcoming investor conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MARSEILLE, France, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Innate Pharma SA (Euronext Paris: IPH \u2013 ISIN: FR0010331421; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d), today announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences. Bryan Garnier &amp; Co Virtual European Healthcare Conference Date: November 17, 2020 Fireside Chat: November 17, 2020 at 10:00 a.m. CET Jefferies Virtual London Healthcare Conference Date: November 18, 2020 SVB Leerink Oncology 1&#215;1 Day Date: November 19, 2020 Oddo &#8211; Tech40 Digital Forum 5 th Edition Date: November 24-25, 2020 Evercore ISI 3 rd Annual HealthCONx Date: December 1-3, 2020 Fireside Chat: December 2, 2020 at 8:50-9:10 a.m. ET A replay of Innate\u2019s presentation at the &hellip; Continue reading &quot;Innate Pharma to Participate in upcoming investor conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T06:03:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzkwMCMzODIwNzc3IzEwMTE0NTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Innate Pharma to Participate in upcoming investor conferences\",\"datePublished\":\"2020-11-12T06:03:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":693,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MzkwMCMzODIwNzc3IzEwMTE0NTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"Innate Pharma to Participate in upcoming investor conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MzkwMCMzODIwNzc3IzEwMTE0NTA=\",\"datePublished\":\"2020-11-12T06:03:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MzkwMCMzODIwNzc3IzEwMTE0NTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MzkwMCMzODIwNzc3IzEwMTE0NTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/innate-pharma-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Innate Pharma to Participate in upcoming investor conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Innate Pharma to Participate in upcoming investor conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Innate Pharma to Participate in upcoming investor conferences - Market Newsdesk","og_description":"MARSEILLE, France, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Innate Pharma SA (Euronext Paris: IPH \u2013 ISIN: FR0010331421; Nasdaq: IPHA) (\u201cInnate\u201d or the \u201cCompany\u201d), today announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences. Bryan Garnier &amp; Co Virtual European Healthcare Conference Date: November 17, 2020 Fireside Chat: November 17, 2020 at 10:00 a.m. CET Jefferies Virtual London Healthcare Conference Date: November 18, 2020 SVB Leerink Oncology 1&#215;1 Day Date: November 19, 2020 Oddo &#8211; Tech40 Digital Forum 5 th Edition Date: November 24-25, 2020 Evercore ISI 3 rd Annual HealthCONx Date: December 1-3, 2020 Fireside Chat: December 2, 2020 at 8:50-9:10 a.m. ET A replay of Innate\u2019s presentation at the &hellip; Continue reading \"Innate Pharma to Participate in upcoming investor conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T06:03:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzkwMCMzODIwNzc3IzEwMTE0NTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Innate Pharma to Participate in upcoming investor conferences","datePublished":"2020-11-12T06:03:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/"},"wordCount":693,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzkwMCMzODIwNzc3IzEwMTE0NTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/","name":"Innate Pharma to Participate in upcoming investor conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzkwMCMzODIwNzc3IzEwMTE0NTA=","datePublished":"2020-11-12T06:03:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzkwMCMzODIwNzc3IzEwMTE0NTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzkwMCMzODIwNzc3IzEwMTE0NTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/innate-pharma-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Innate Pharma to Participate in upcoming investor conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=379192"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379192\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=379192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=379192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=379192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}